RT Journal Article
SR Electronic
A1 Hoyle, Brian
T1 Armodafinil Shows Potential Benefit for Depressive Symptoms in Bipolar Disorder
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 8
SP 12
OP 13
DO 10.1177/155989771408003
UL http://mdc.sagepub.com/content/14/8/12.abstract
AB Armodafinil 150 mg daily for 8 weeks as an adjuvant with mood stabilizers and/or antipsychotic drugs improved depressive symptoms associated with bipolar I disorder. The benefits, however, were not statistically significant compared with placebo. The findings of a multi-institutional, international, Phase 3, randomized, double-blind, placebo-controlled trial are discussed in this article [APA 2014 (poster NR6-038); NCT01305408].